First test of new drug in healthy volunteers
Knowledge-focused
Recruiting now
This is the first study in humans for a new drug called SYNT-101. It aims to check the safety and how the body processes the drug in 64 healthy adults, including some who are overweight. Participants will receive either the drug or a placebo, and researchers will monitor for any …
Phase: PHASE1 • Sponsor: Syntis Bio • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC